Computationally designed antibody-drug conjugates self-assembled via
affinity ligands.
Nature Biomedical Engineering, 2019
Gupta N, Ansari A, Dhoke GV, Chilamari M, Sivaccumar J, Kumari S,
Chatterjee S, Goyal R, Dutta PK, Samarla M, Mukherjee M, Sarkar A, Mandal SK, Rai V,
Biswas G, Sengupta A, Roy S, Roy M, Sengupta S.
|
|
|
|
Transcellular transfer of nanomedicine
Nature Nanotechnology, 2019
Jang HL, Sengupta S
|
|
|
|
Targeting tumor phenotypic plasticity and metabolic remodeling in
adaptive cross-drug tolerance.
Science Signaling, 2019.
Goldman A, Khiste S, Freinkman E, Dhawan A, Majumder B, Mondal J,
Pinkerton AB, Eton E, Medhi R, Chandrasekar V, Rahman MM, Ichimura T, Gopinath KS,
Majumder P, Kohandel M, Sengupta S.
|
|
|
|
A Microfabricated Sandwiching Assay for Nanoliter and
High-Throughput Biomarker Screening.
Small, 2019.
Bandaru P, Chu D, Sun W, Lasli S, Zhao C, Hou S, Zhang S, Ni J, Cefaloni G, Ahadian S,
Dokmeci MR, Sengupta S, Lee J, Khademhosseini A.
|
|
|
|
Organ-on-a-Chip for Cancer and Immune Organs Modeling.
Advanced Healthcare Material, 2019.
Sun W, Luo Z, Lee J, Kim HJ, Lee K, Tebon P, Feng Y, Dokmeci MR, Sengupta S,
Khademhosseini A.
|
|
|
|
Applications of nanotechnology for regenerative medicine; Healing
tissues at the nanoscale.
Principles of regenerative medicine. 3rd ed. Academic Press; 2019.
Yang Y, Chawla A, Zhang J, Esa A, Jang HL*, Khademhosseini A
|
|
|
|
A designer self-assembled supramolecule amplifies macrophage immune
responses against aggressive cancer
Nature Biomedical Engineering, 2018
Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar
Natarajan, Anujan Ramesh, Prithviraj Pandey, Jayashree Nirgud, Harshangda Bhatnagar,
Driti Ashok, Amrendra Kumar Ajay,and Shiladitya Sengupta
|
|
|
|
A rationally designed multi-functional antibiotic for the treatment
of drug-resistant acne.
J Invest Dermatol, 2018.
Ghosh S, Sinha M, Bhattacharyya A, Sadhasivam S, Megha J, Reddy S, Saini S, Singh H,
Kumar D, Kaur SP, Mishra M, Usharani D, Ghosh S, Sengupta S.
|
|
|
|
Injectable shear thinning hydrogels for delivering osteogenic and
angiogenic cells and growth factors.
Biomaterial Science, 2018.
Alarçin E, Lee TY, Karuthedom S, Mohammadi M, Brennan MA, Lee DH, Marrella A, Zhang J,
Syla D, Zhang YS*, Khademhosseini A*, Jang HL
|
|
|
|
Synergistic interplay between the two major bone minerals,
hydroxyapatite and whitlockite nanoparticles, for osteogenic differentiation of
mesenchymal stem cells.
Acta Biomaterialia, 2018.
Cheng H, Chabok R, Guan X, Chawla A, Li Y, Khademhosseini A*, Jang HL*
|
|
|
|
Development of a facile antibody-drug conjugate platform for
increased stability and homogeneity.
Chem Sci., 2017
Gupta N, Kancharla J, Kaushik S, Ansari A, Hossain S, Goyal R,
Pandey M, Sivaccumar J, Hussain S, Sarkar A, Sengupta A, Mandal SK, Roy M ,Sengupta
S.
|
|
|
|
Cancer nanomedicine: lessons for immuno-oncology.
Trends Cancer, 2017.
Sengupta S.
|
|
|
|
Evaluation of therapeutic potential of vb-001, a leave-on
formulation, for the treatment of moderate adherent dandruff.
BMC Dermatol, 2017.
Bhattacharyya A, Jain N, Prasad S, Jain S, Yadav V, Ghosh S, Sengupta S.
|
|
|
|
3D printed anchoring sutures for permanent shaping of tissues.
MacromolBiosci, 2017.
Wei W, Li Y, Yang H, Nassab R, Shahriyari F, Akpek A, Guan X, Liu Y, Taranejoo S,
Tamayol A, Zhang YS, Khademhosseini A*, Jang HL*.
|
|
|
|
Chondroitin sulfate-based biomineralizing surface hydrogels for bone
tissue engineering.
ACS Appl Mater Interfaces, 2017.
Kim HD, Lee EA, An YH, Kim SL, Lee SS, Yu SJ, Jang HL, Nam KT, Im SG, Hwang NS.
|
|
|
|
Cold‐spray coating of hydroxyapatite on a three‐dimensional
polyetheretherketone implant and its biocompatibility evaluated by in vitro and in vivo
minipig model.
J Biomed Mater Res B Appl Biomater, 2017.
Lee JH*, Jang HL*, Lee KM, Baek HR, Jin K, Noh JH.
|
|
|
|
Biomimetic whitlockite inorganic nanoparticles-mediated in situ
remodeling and rapid bone regeneration.
Biomaterials, 2017.
Kim HD*, Jang HL*, Ahn HY, Lee HK, Park J, Lee ES, Lee EA, Jeong YH, Kim DG, Nam KT,
Hwang NS
|
|
|
|
Rapid continuous multimaterial extrusion bioprinting.
Advanced Material, 2017.
Liu W, Zhang YS, Heinrich MA, Ferrari FD, Jang HL, Bakht SM, Alvarez MM, Yang J, Li Y,
Santiago G, Miri AK, Khoshakhlagh P, Prakash G, Cheng H, Guan X, Zhong Z, Ju J, Zhu G,
Jin X, Shin SR, Dokmeci MR, Khademhosseini A.
|
|
|
|
Engineering vascularized and innervated bone biomaterials for
improved skeletal tissue regeneration.
Materials Today, 2017.
Marrella A, Lee TY, Lee DH, Karuthedom S, Syla D, Chawla A, Khademhosseini A*, Jang
HL*.
|
|
|
|
Development of nanomaterials for bone targeted drug delivery.
Drug Discovery Today, 2017.
Cheng H, Chawla A, Yang Y, Li Y, Zhang J, Jang HL*, Khademhosseini A*.
|
|
|
|
Development of hydrogels for regenerative engineering.
Biotechnol J, 2017.
GuanX, Avci-Adali M, Alarçin E, Cheng H, Kashaf SS, Li Y, Chawla A, Jang HL*,
Khademhosseini A*.
|
|
|
|
Rationally designed 2-in-1 nanoparticles can overcome adaptive
resistance in cancer
ACS Nano, 2016
Aaron Goldman, Ashish Kulkarni, Mohammad Kohandel, Prithvi
Pandey, Poornima Rao, Siva Kumar Natarajan, Venkata Sabbisetti, Shiladitya Sengupta
|
|
|
|
Combining immune checkpoint inhibitors and kinase-inhibiting
supramolecular therapeutics for enhanced anti-cancer efficacy
ACS Nano, 2016
Kulkarni A. A., Natarajan S. K., Chandrasekar V., Pandey P,
Sengupta S.
|
|
|
|
Algorithm for designing nanoscale supramolecular therapeutics with
increased anticancer efficacy
ACS Nano, 2016
Ashish Kulkarni, Prithvi Pandey, Poornima Rao, Ayaat Mahmoud,
Aaron Goldman, Venkata Sabbisetti, Shashikanth Parcha, Siva Kumar Natarajan,
Vineethkrishna Chandrasekar, Daniela Dinulescu, Sudip Roy, Shiladitya Sengupta
|
|
|
|
Heterogeneity and antibiotic resistance in Propionibacterium acnes
strains and its therapeutic implications: blurring the lines between commensal and
pathogenic phylotypes.
Dermatol Ther, 2016.
Sadhasivam S, Sinha M, Saini S, Kaur SP, Gupta T, Sengupta S, Ghosh S, Sardana K.
|
|
|
|
Boosting clinical translation of nanomedicine.
Nanomedicine, 2016.
Jang HL, Zhang YS, Khademhosseini A.
|
|
|
|
Recreating composition, structure, functionalities of tissues at
nanoscale for regenerative medicine.
Regen Med, 2016.
Alarçin E, Guan X, Kashaf SS, Elbaradie K, Jang HL*, Khademhosseini A*
|
|
|
|
Graphene-based materials for tissue engineering.
Adv Drug Deliv Rev, 2016.
Shin SR, Li YC, Jang HL, Khoshakhlagh P, Akbari M, Nasajpour A, Zhang YS, Tamayol A,
Khademhosseini A.
|
|
|
|
Dynamic microenvironment induces phenotypic plasticity of esophageal
cancer cells under flow.
Scientific Report, 2016.
Calibasi Kocal G, Güven S, Foygel K, Goldman A, Chen P, Sengupta S, Paulmurugan R,
Baskin Y, Demirci U
|
|
|
|
Supramolecular fusion nanotherapeutic- mediated synergistic
inhibition of pi3k and mek pathways.
AACR Annual Meeting, 2016, New Orleans, LA.
Chandrasekar V, Natarajan SK, Sengupta S, Kulkarni A. A.
|
|
|
|
Sustained inhibition of cmet-vegfr2 signaling using
liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer.
Nanomedicine, 2016.
Kulkarni AA, Vijaykumar VE, Natarajan SK, Sengupta S, Sabbisetti VS
|
|
|
|
Rationally designed 2-in-1 nanoparticles can overcome adaptive
resistance in cancer.
ACS Nano, 2016.
Goldman A, Kulkarni AA, Kohandel M, Pandey PR, Rao P, Natarajan S, Sabbisetti VS,
Sengupta S.
|
|
|
|
Algorithm for designing nanoscale supramolecular therapeutics with
increased anticancer efficacy.
ACS Nano, 2016.
Kulkarni AA, Pandey P, Rao P. S., Wyant G., Mahmoud A, Goldman A, Kotamraju VR,
Ruoslahti E, Dinulescu D, Roy S, Sengupta S
|
|
|
|
Combining immune checkpoint inhibitors and kinase-inhibiting
supramolecular therapeutics for enhanced anti-cancer efficacy.
ACS Nano, 2016.
Kulkarni AA, Natarajan SK, Chandrasekar V, Pandey P, Sengupta S.
|
|
|
|
Reporter nanoparticle that monitors its anticancer efficacy in real
time.
Proceedings of National Academy of Sciences U S A, 2016.
Kulkarni AA, Rao P, Natarajan S, Goldman A, Sabbisetti V, Khater Y, Korimerla N,
Mashelkar R, Sengupta S.
|
|
|
|
Drug-induced reactive oxygen species (ROS) rely on cell membrane
properties to exert anticancer effects.
Scientific Report, 2016.
Molavian HR, Goldman A, Phipps CJ, Kohandel M, Wouters BG, Sengupta S, Sivaloganathan
S.
|
|
|
|
Notch-jagged signalling can give rise to clusters of cells
exhibiting a hybrid epithelial/mesenchymal phenotype.
J R Soc Interface, 2016.
Boareto M, Jolly MK, Goldman A, Pietilä M, Mani SA, Sengupta S, Ben-Jacob E, Levine H,
Onuchic JN.
|
|
|
|
Antibiotic-resistant acne: getting under the skin.
SeminCutan Med Surg, 2016.
Sinha M, Sadhasivam S, Bhattacharyya A, Jain S, Ghosh S, Arndt KA, Dover JS, Sengupta
S.
|
|
|
|
In vitro and in vivo evaluation of whitlockite biocompatibility:
comparative study with hydroxyapatite and β-tricalcium phosphate.
Advanced Healthcare Material, 2016.
Jang HL*, Zheng GB*, Park J, Kim DH, Baek HR, Lee HK, Lee K, Han HN, Lee CK, Hwang NS,
Lee JH, Nam KT.
|
|
|
|
Supramolecular nanoparticles that target mapk pathway synergizes
with immune checkpoint inhibitor in melanoma
AACR Annual Meeting, Philadelphia, PA, 2015.
Kulkarni AA, Sabbisetti V, Sengupta S.
|
|
|
|
Engineering of supramolecular taxane nanoparticles by
computationally modeling drug-lipid bilayer interactions.
Experimental Biology Meeting, 2015, Boston, MA.
Kulkarni A, Pandey P, Rao P, Goldman G, Roy S, Sengupta S
|
|
|
|
Temporally sequenced anticancer drugs overcome adaptive resistance
by targeting a vulnerable chemotherapy-induced phenotypic transition.
Nature Communication, 2015.
Goldman A. Majumder B, Dhawan A, Ravi S, Goldman D, Kohandel M, Majumder MK, Sengupta
S.
|
|
|
|
Predicting clinical response to anticancer drugs using an ex vivo
platform that captures tumour heterogeneity.
Nature Communication, 2015.
Majumder B, Baraneedharan U, Thiyagarajan S, Radhakrishnan P, Narasimhan H, Dhandapani
M, Brijwani N, Pinto DD, Prasath A, Shanthappa BU, Thayakumar A, Surendran R, Babu G,
Shenoy AM, Kuriakose MA, Bergthold G, Horowitz P, Loda M, Beroukhim R, Agarwal S,
Sengupta S*, Sundaram M*, Majumder PK*.
|
|
|
|
Physical nanoscale conduit-mediated communication between tumor
cells and the endothelium modulates endothelial phenotype.
Nature Communication, 2015.
Connor Y, Tekleab S, Nandakumar S, Walls C, Tekleab Y, Husain A, Gadish O, Sabbisetti V,
Kaushik S, Sehrawat S, Kulkarni A, Dvorak H, Zetter B, Edelman E, Sengupta S.
|
|
|
|
Nano-hydroxyapatite modulates osteoblast lineage commitment by
stimulation of DNA methylation and regulation of gene expression.
Biomaterials, 2015.
Ha SW, Jang HL, Nam KT, Beck GR.
|
|
|
|
Hybrid Z-scheme using photosystem I and BiVO4 for hydrogen
production.
Advanced Functional Material, 2015.
Kim Y, Shin D, Chang WJ, Jang HL, Lee CW, Lee HE, Nam KT
|
|
|
|
Biofunctionalized ceramic with self-assembled networks of
nanochannels.
ACS Nano, 2015.
Jang HL, Lee K, Kang CS, Lee HK, Ahn HY, Jin K, Park S, Kim SC, Yang TY, Jeong HY, Park
J, Kim JH, Shin SA, Han HN, Oh KH, Lee H, Hong KS, Lim J, Snead LM, Xu J, Nam KT.
|
|
|
|
Phase transformation from hydroxyapatite to the secondary bone
mineral, whitlockite.
J Mater Chem B, 2015.
Jang HL, Lee HK, Jin K, Ahn H, Lee H, Nam KT.>
|
|
|
|
Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by
enhancing tumor vasculature permeability and drug delivery.
Nanotechnology, 2014.
Pandey A, Sarangi S, Chien K, Sengupta P, Papa AL, Basu S, Sengupta S.
|
|
|
|
Targeting chemotherapy induced adaptive resistance using hybrid
nanoparticles (LB577).
The FASEB Journal, 2014.
Kulkarni A, Rao P, Goldman A, Sengupta S.
|
|
|
|
Computationally-inspired engineering of supra-molecular taxane
nanoparticles.
Cancer Research, 2014.
Kulkarni AA, Rao P, Goldman A, Sengupta S.
|
|
|
|
Clinical translational challenges in nanomedicine.
MRS Bull, 2014.
Sengupta S.
|
|
|
|
Sequential application of a cytotoxic nanoparticle and a
pi3k-inhibitor enhances anti-tumor efficacy.
Cancer Research, 2014.
Pandey A, Kulkarni A, Roy B, Goldman A, Sarangi S, Sengupta P, Phipps C, Kopparam J, Oh
M, Basu S, Kohandel M, Sengupta S.
|
|
|
|
Hydrated Manganese (II) Phosphate (Mn3(PO4)2-3H2O) as a water
oxidation catalyst.
J Am Chem Soc, 2014.
Jin K, Park J, Lee J, Yang KD, Pradhan GK, Sim U, Jeong D, Jang HL, Park S, Kim D, Sung
N, Kim SH, Han S, Nam KT.
|
|
|
|
PEGylated liposomal Gemcitabine: insights into a potential breast
cancer therapeutic.
Cell Oncol, 2013.
apa A, Sidiqui A, Balasubramanian SUA, Sarangi S, Luchette M, Sengupta S, Harfouche R.
|
|
|
|
Supramolecular nanoparticles that target
phosphatidylinositol-3-kinase overcome insulin resistance and exert pronounced antitumor
efficacy.
Cancer Research, 2013.
Kulkarni AK, Roy B, Rao PS, Wyant GA, Mahmoud A, Ramachandran M, Sengupta P, Goldman A,
Kotamraju VR, Basu B, Mashelkar RA, Ruoslahti E, Dinulescu DM, Sengupta S.
|
|
|
|
P2Y12 Receptor inhibition augments cytotoxic effects of cisplatin in
breast cancer.
Med. Oncol,2013.
Sarangi S, Pandey A, Papa AL, Sengupta P, Kopparam J, Dadwal U, Basu S, Sengupta S.
|
|
|
|
Design principles for clinical efficacy of cancer nanomedicine: a
look into the basics.
ACS Nano,2013.
Sengupta S, Kulkarni A.
|
|
|
|
Rationally designed oxaliplatin nanoparticle for enhanced antitumor
efficacy.
Nanotechnology, 2012.
Paraskar A, Soni S, Roy B, Papa AL, Sengupta S.
|
|
|
|
Revisiting whitlockite, the second most abundant biomineral in bone:
nanocrystal synthesis in physiologically relevant conditions and biocompatibility
evaluation.
ACS Nano,2013.
Jang HL, Jin K, Lee J, Kim Y, Nahm SH, Hong KS, Nam KT.
|
|
|
|
In vitro and in vivo evaluation of the bioactivity of hydroxyapatite
coated polyetheretherketone biocomposites created by cold spray technology.
Acta Biomater,2013.
Lee JH*, Jang HL*, Lee KM, Baek H, Jin K, Hong KS, Noh JH, Lee H.
|
|
|
|
Mechanistic studies of gemcitabine-loaded nanoplatforms in resistant
pancreatic cancer cells.
BMC Cancer, 2012.
Papa AL, Basu S, Sengupta P, Banerjee D, Sengupta S, Harfouche R
|
|
|
|
Intercellular transfer between metastatic breast cancer and the
endothelium mediated by tunneling nanotubes.
Cancer Research, 2012.
Connor YD, Tekleab S, Gill NK, Bharat D, Lloyd T, Walls CR, Sengupta S.
|
|
|
|
A cholesterol-tethered platinum ii-based supramolecular nanoparticle
increases antitumor efficacy and reduces nephrotoxicity.
Proceedingsof National Academy of Sciences U S A, 2012.
Sengupta P, Basu S, Soni S, Pandey A, Oh M, Chin KT, Paraskar AS, Roy B, Sarangi S,
Connor Y, Sabbisetti V, Kopparam J, Amarasiriwardena C, Jayawardene I, Lupoli N,
Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S.
|
|
|
|
Insulin-like growth factors promote vasculogenesis in embryonic stem
cells.
PLoS One,2012.
Piecewicz SM, Pandey A, Roy B, Hua Xiang S, Zetter BR, Sengupta S
|
|
|
|
Rationally engineered polymeric cisplatin nanoparticles for improved
antitumor efficacy.
Nanotechnology, 2011.
Paraskar A, Soni S, Basu S, Amarasiriwardena CJ, Lupoli N, Srivats S, Roy RS, Sengupta
S.
|
|
|
|
Quantitative model for efficient temporal targeting of tumor cells
and neovasculature.
Comput Math Methods Med, 2011.
Kohandel M, Haselwandter C, Kardar M, Sengupta S, Sivaloganathan S.
|
|
|
|
Cancer, signal transduction and nanotechnology.
Current Drug Deliv, 2011.
Sengupta P, Basu S, Sengupta S.
|
|
|
|
The dynamic glycome microenvironment and stem cell differentiation
into vasculature.
Stem Cells Dev, 2011.
Piecewicz S, Sengupta S.
|
|
|
|
Emerging technologies for enabling proangiogenic therapy.
Nanotechnology, 2011.
Roy RS, Roy B, Sengupta S
|
|
|
|
Nanoparticles in cancer chemotherapy
Nanoparticles in translational science and medicine,Progress in molecular biology and
translational science: Waltham, MA: Academic Press.
2011.
Banerjee D, Sengupta S.
|
|
|
|
Nanotechnology-mediated targeting of tumor angiogenesis.
Vasc Cell, 2011.
Banerjee D, Harfouche R, Sengupta S
|
|
|
|
Harnessing structure-activity relationship to engineer a novel
cisplatin nanoparticle for improved antitumor efficacy.
Proceedingsof National Academy of Sciences U S A. 2010.
Paraskar A, Chin KT, Chaudhuri P, Muto KW, Berkowitz J, Handlogten MW, Alves NJ,
Bilgicer B, Dinulescu DM, Mashelkar RA, Sengupta S
|
|
|
|
The Bittersweet Promise of Glycobiology.
Biomarkers: In Medicine, Drug Discovery, and Environmental Health. Hoboken N.J.: Wiley
Press, 2010.
Chaudhuri P, Harfouche R, Sengupta S.
|
|
|
|
Coupling growth factor engineering with nanotechnology for
therapeutic angiogenesis.
Proceedings of National Academy of Sciences U S A, 2010.
Sinha Roy R, Soni S, Harfouche R, Vasudevan P, Holmes O, de Jonge H, Rowe A, Paraskar A,
Hentschel DM, Gherardi E, Mashelkar RA, Sengupta S.
|
|
|
|
Modeling interactions between endothelial cells and metastatic
breast cancer cells in a three-dimensional culture.
AACR 101st Annual Meeting, Washington, DC 2010.
Connor Y, Harfouche R, Liu C, Oh M, Sengupta S.
|
|
|
|
Integrating novel protein engineering and nanotechnology for
therapeutic angiogenesis.
Experimental Biology Meeting, 2010. Published in FASEBJ, 2010.
Sinha-Roy R, Soni S, Harfouche R, Vasudevan PR, Paraskar A, Sengupta S.
|
|
|
|
Ranking chemical structures for drug discovery: a new machine
learning approach.
J Chem Inf Model, 2010.
Agarwal S, Dugar D, Sengupta S.
|
|
|
|
Shape effect of carbon nanovectors on angiogenesis.
ACS Nano. 2010.
Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S.
|
|
|
|
Single-walled carbon nanotube-conjugated chemotherapy exhibits
increased therapeutic index in melanoma.
Nanotechnology, 2010.
Chaudhuri P, Soni S, Sengupta S.
|
|
|
|
Simple large-scale synthesis of hydroxyapatite nanoparticles: in
situ observation of crystallization process.
Langmuir, 2010.
Kim DW, Cho I, Kim JY, Jang HL, Han GS, Ryu H, Shin H, Jung HS, Kim H, Hong KS.
|
|
|
|
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor
to chemotherapy.
Proceedings of National Academy of Sciences U S A, 2009.
Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S.
|
|
|
|
Glycome and transcriptome regulation of vasculogenesis.
Circulation, 2009.
Harfouche R, Hentschel D, Piecewicz, Basu S, Print C, Eavarone D, Kiziltepe T,
Sasisekharan R, Sengupta S.
|
|
|
|
Emerging innovation practices and policies for the health-care needs
of resource-poor people.
Global Forum Update on Research for Health, 2009.
Mashelkar RA, Patwardhan B, Sengupta S.
|
|
|
|
Fullerenol-cytotoxic conjugates for cancer chemotherapy.
ACS Nano, 2009.
Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S.
|
|
|
|
Angiogenesis.
Drug Screening Methods. New Delhi, India: Jaypee Brothers Medical Publishers, 2009.
Sengupta S.
|
|
|
|
Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase
signaling inhibits angiogenesis.
Angiogenesis, 2009.
Harfouche R, Basu S, Soni S, Hentschel D, Mashelkar RA, Sengupta S.
|
|
|
|
A novel embryonic stem cell differentiation system for
high-throughput antiangiogenesis screening.
FASEB J, 2009.
Piecewizc S, Harfouche R, Hentschel D, Basu S, Sengupta S.
|
|
|
|
Targeting oncogenic signaling pathways by exploiting
nanotechnology.
Cell Cycle, 2009.
Basu S, Chaudhuri P, Sengupta S.
|
|
|
|
Searching for glycomics role in vasculogenesis.
Bioinformatics, 2008.
Sorathyia A, Jucikas T, Piecewicz S, Sengupta S, Lio P.
|
|
|
|
Exploiting nanotechnology to target cancer.
Br J Cancer, 2007.
Sengupta S, Sasisekharan R.
|
|
|
|
Chemical genetic analysis of glycome regulation in
vasculogenesis.
Experimental Biology Conference, 2007.
Piecewicz S, Sengupta S, Hentschel DM.
|
|
|
|
Temporal targeting of tumour cells and neovasculature with a
nanoscale delivery system.
Nature, 2005.
Sengupta S, Eavarone DA, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R.
|
|
|
|
Nitric oxide modulates hepatocyte growth factor induced
angiogenesis.
Angiogenesis, 2004.
Sengupta S, Sellers LA, Gherardi E, Sasisekharan R, Fan TP.
|
|
|
|
Modulating angiogenesis- the yin and the yang in ginseng.
Circulation, 2004.
Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk P, Leung HW, Yeung HW, Wong RNS,
Sasisekharan R, Fan TP.
|
|
|
|
Endothelial cells preparing to die by apoptosis initiate a program
of transcriptome and glycome regulation.
FASEB J, 2004.
Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R,
Freeman TC, Tom BDM, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print
CG.
|
|
|
|
A dual color fluorescence imaging-based system for the dissection of
antiangiogenic and chemotherapeutic activity of molecules.
FASEB J, 2004.
Sengupta S, Kiziltepe T, Sasisekharan R.
|
|
|
|
Delivery of therapeutic levels of heparin and low molecular weight
heparin through a pulmonary route.
Proceedingsof National Academy of Sciences U S A, 2004.
Qi Y, Zhao G, Liu D, Shriver Z, Sundaram M, Sengupta S, Venkataraman G, Langer R,
Sasisekharan R.
|
|
|
|
Hepatocyte growth factor/scatter factor can induce angiogenesis
independently of vascular endothelial growth factor.
ArteriosclerThrombVasc Biol, 2003.
Sengupta S, Gherardi E, Sellers LA, Sasisekharan R, Fan TP.
|
|
|
|
Thymidine phosphorylase induces angiogenesis in vitro and in vivo:
an evaluation of possible mechanisms.
Br J Pharmacol. 2003
Sengupta S, Sellers LA, Matheson HB, Fan TP.
|
|
|
|
Targeting of mitogen activated protein kinases and
phosphatidylinositol 3 kinase inhibits hepatocyte growth factor/scatter factor-induced
angiogenesis.
Circulation, 2003.
Sengupta S, Seller LA, Li R, Zhao G, Gherardi E, Sasisekharan R, Fan TP.
|
|
|
|
Cyclooxygenase-2-selective non-steroidal anti-inflammatory drugs
inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
Cancer Research, 2003.
Sengupta S, Sellers LA, Cindrova T, Skepper JN, Gherardi E, Sasisekheran R, Fan TP.
|
|
|
|
A study of the signaling mechanisms of selected angiogenic
promoters.
University of Cambridge, 2002.
Sengupta S.
|
|
|
|
Encapsulation in cationic liposomes enhances antitumour efficacy and
reduces the toxicity of etoposide, a topo-isomerase ii inhibitor.
Pharmacology, 2001.
Sengupta S, Tyagi P, Chandra S, Kochupillai V, Gupta SK.
|
|
|
|
Angiogenesis: Concepts and research methodologies.
Pharmacology and Therapeutics in the New Millennium. New Delhi, India: Springer,
2001.
Sengupta S, Gupta S K.
|
|
|
|
Autoimmune diseases.
Blakemore C, Jennett S, editors. The Oxford Companion to the Body. Oxford UK: Oxford
University Press, 2001.
Sengupta S, Fan T-P D.
|
|
|
|
Immunity.
The Oxford Companion to the Body. Oxford, UK: Oxford University Press, 2001.
Sengupta S, Fan T-P D.
|
|
|
|
Etoposide encapsulated in positively charged liposomes:
pharmacokinetic studies in mice and formulation stability studies.
Pharmacol Res, 2000.
Sengupta S, Tyagi P, Velpandian T, Gupta Y K, Gupta S K.
|
|
|
|
Anti-inflammatory activity and pharmacokinetic profile of a new
parenteral formulation of nimesulide.
Pharmacol Res,1999.
Gupta SK, Bhardwaj RK, Tyagi P, Sengupta S, Velpandian T.
|
|
|
|
Expression of inducible and neuronal nitric oxide synthase in
20-methyl cholanthrene (20-mca) induced fibrosarcoma.
Ind J Pharmacol, 1999.
Sengupta S, Sanyal M, Kochupillai V, Gupta SK.
|
|
|
|
Evaluation of the antitumour activity of liposomal formulations of
etoposide against choriocarcinoma xenografts in balb/c nu/nu mice.
Pharm PharmacolCommun, 1999.
Tyagi P, Sengupta S, Velpandian T, Gupta Y K, Kochupillai V, Gupta SK.
|
|
|
|
Analgesic efficacy and pharmacokinetics of topical nimesulide gel in
healthy human volunteers: double-blind comparison with piroxicam, diclofenac and
placebo.
Eur J Clin Pharmacol, 1998.
Sengupta S, Velpandian T, Kabir SR, Gupta SK.
|
|
|
|
Preventive effect of chyavanprash against steroid induced cataract
in the developing chick embryo.
Phytother Res, 1998.
Velpandian T, Mathur P, Sengupta S, Gupta SK.
|
|
|
|
Comparative analgesic efficacy of nimesulide and diclofenac gels
after topical application on the skin.
Skin Pharmacol Appl Skin Physiol, 1998.
Sengupta S, Velpandian T, Sapra P, Mathur P, Gupta SK.
|
|
|
|
Influence of piperine on nimesulide induced antinociception.
Phytother Res, 1998.
Gupta SK, Velpandian T, Sengupta S, Mathur P, Sapra P.
|
|
|
|
Comparative analgesic activity of nimesulide and diclofenac by
intramuscular route: correlation with pharmacokinetic profile of nimesulide.
Pharmacology, 1998.
Gupta SK, Velpandian T, Mathur P, Sengupta S.
|
|
|
|
Anti-inflammatory activity of topical nimesulide gel in various
experimental models.
Inflamm Res, 1996.
Gupta SK, Prakash J, Awor L, Joshi S, Velpandian T, Sengupta S.
|
|
|